title: The Common FTO Genetic Polymorphism rs9939609 is Associated with Increased BMI in Type 1 Diabetes but not with Diabetic Nephropathy.
abstract: The fat mass and obesity associated (FTO) gene has an important genetic effect on body mass index (BMI) and risk of obesity, and obesity contributes to the progression of renal diseases, including diabetic nephropathy. We thus conducted a genetic association study to evaluate whether the FTO gene confers the risk susceptibility to the development of diabetic nephropathy. Genotyping experiments of the common FTO polymorphism, rs9939609, in 1170 type 1 diabetes patients with (n = 597) or without diabetic nephropathy (n = 573) were performed with TaqMan allelic discrimination. All subjects are of European descent and selected from the Genetics of Kidney Diseases in Diabetes (GoKinD) study. The frequency of T allele of this polymorphism was 0.414 in the studied population. There was no allelic association of this polymorphism with diabetic nephropathy. But, the risk susceptibility of A allele conferring to the increased BMI among type 1 diabetes patients was observed. The subjects carrying with AA genotype had higher BMI compared to the carriers with TA and/or TT genotype(s) (P </= 0.019). The present study provides evidence that the common FTO genetic polymorphism, rs9939609, is associated with increased BMI in type 1 diabetes but not with diabetic nephropathy.
authors.affiliation: Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden. Email: harvest.gu@ki.se.
authors.forename: Harvest F
authors.initials: HF
authors.lastname: Gu
authors.forename: Alexandra
authors.initials: A
authors.lastname: Alvarsson
authors.forename: Kerstin
authors.initials: K
authors.lastname: Brismar
references.citation: PLoS One. 2007 Dec 26;2(12):e1361
references.pmid: 18159244
references.citation: Science. 2007 May 11;316(5826):889-94
references.pmid: 17434869
references.citation: Diabetologia. 2007 Oct;50(10):2218-20
references.pmid: 17657473
references.citation: Diabetes. 2008 Sep;57(9):2480-7
references.pmid: 18544706
references.citation: Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):100-10
references.pmid: 16929378
references.citation: Clin J Am Soc Nephrol. 2009 Oct;4(10):1565-74
references.pmid: 19808241
references.citation: Curr Diab Rep. 2007 Dec;7(6):449-53
references.pmid: 18255009
references.citation: Am J Nephrol. 2009;29(3):244-51
references.pmid: 18802326
references.citation: J Am Soc Nephrol. 2006 Jul;17(7):1782-90
references.pmid: 16775037
references.citation: Nat Genet. 2007 Jun;39(6):724-6
references.pmid: 17496892
references.citation: Science. 2007 Jun 1;316(5829):1341-5
references.pmid: 17463248
references.citation: Microcirculation. 2007 Jun-Jul;14(4-5):349-62
references.pmid: 17613807